Literature DB >> 33467981

Identification of key residues involved in the neuraminidase antigenic variation of H9N2 influenza virus.

Fei Wang1,2, Jinsen Wu1,2, Yajuan Wang1,2, Zhimin Wan1,2,3, Hongxia Shao1,2,3, Kun Qian1,2,3, Jianqiang Ye1,2,3, Aijian Qin1,2,3.   

Abstract

Influenza A H9N2 virus causes economic loss to the poultry industry and has likely contributed to the genesis of H5N1 and H7N9 viruses. The neuraminidase (NA) of H9N2 virus, like haemagglutinin, is under antibody selective pressure and may undergo antigenic change; however, its antigenic structure remains to be elucidated. In this study, we used monoclonal antibodies (mAbs) to probe the H9N2 viral NA residues that are key for antibody binding/inhibition. These mAbs fell into three groups based on their binding/inhibition of the NA of H9N2 viruses isolated during 1999-2019: group I only bounded the NA of the early 2000 H9N2 viruses but possessed no neutralizing ability, group II bounded and inhibited the NA of H9N2 viruses isolated before 2012, and group III reacted with most or all tested H9N2 viruses. We showed that NA residue 356 is key for the recognition by group I mAbs, residues 344, 368, 369, and 400 are key for the binding/inhibition of NA by group II antibodies, whereas residues 248, 253, and the 125/296 combination are key for neutralizing antibodies in group III. Our findings highlighted NA antigenic change of the circulating H9N2 viruses, and provided data for a more complete picture of the antigenic structure of H9N2 viral NA.

Entities:  

Keywords:  H9N2; Influenza virus; antigenic change; key residues; monoclonal antibodies; neuraminidase

Mesh:

Substances:

Year:  2021        PMID: 33467981      PMCID: PMC7872579          DOI: 10.1080/22221751.2021.1879602

Source DB:  PubMed          Journal:  Emerg Microbes Infect        ISSN: 2222-1751            Impact factor:   7.163


  31 in total

1.  Human infection with influenza H9N2.

Authors:  M Peiris; K Y Yuen; C W Leung; K H Chan; P L Ip; R W Lai; W K Orr; K F Shortridge
Journal:  Lancet       Date:  1999-09-11       Impact factor: 79.321

2.  Human infection with a novel avian-origin influenza A (H7N9) virus.

Authors:  Rongbao Gao; Bin Cao; Yunwen Hu; Zijian Feng; Dayan Wang; Wanfu Hu; Jian Chen; Zhijun Jie; Haibo Qiu; Ke Xu; Xuewei Xu; Hongzhou Lu; Wenfei Zhu; Zhancheng Gao; Nijuan Xiang; Yinzhong Shen; Zebao He; Yong Gu; Zhiyong Zhang; Yi Yang; Xiang Zhao; Lei Zhou; Xiaodan Li; Shumei Zou; Ye Zhang; Xiyan Li; Lei Yang; Junfeng Guo; Jie Dong; Qun Li; Libo Dong; Yun Zhu; Tian Bai; Shiwen Wang; Pei Hao; Weizhong Yang; Yanping Zhang; Jun Han; Hongjie Yu; Dexin Li; George F Gao; Guizhen Wu; Yu Wang; Zhenghong Yuan; Yuelong Shu
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

3.  Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants.

Authors:  M R Lentz; G M Air; W G Laver; R G Webster
Journal:  Virology       Date:  1984-05       Impact factor: 3.616

4.  The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.

Authors:  Hongquan Wan; Jin Gao; Hua Yang; Shuang Yang; Ruth Harvey; Yao-Qing Chen; Nai-Ying Zheng; Jessie Chang; Paul J Carney; Xing Li; Ewan Plant; Lianlian Jiang; Laura Couzens; Carol Wang; Shirin Strohmeier; Wells W Wu; Rong-Fong Shen; Florian Krammer; John F Cipollo; Patrick C Wilson; James Stevens; Xiu-Feng Wan; Maryna C Eichelberger; Zhiping Ye
Journal:  Nat Microbiol       Date:  2019-08-12       Impact factor: 17.745

5.  Genetic characterization of the first detected human case of low pathogenic avian influenza A/H9N2 in sub-Saharan Africa, Senegal.

Authors:  Mamadou Malado Jallow; Amary Fall; Mamadou Aliou Barry; Boly Diop; Sara Sy; Déborah Goudiaby; Malick Fall; Vincent Enouf; Mbayame Ndiaye Niang; Ndongo Dia
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

6.  Co-infection of broilers with Ornithobacterium rhinotracheale and H9N2 avian influenza virus.

Authors:  Qing Pan; Aijing Liu; Faming Zhang; Yong Ling; Changbo Ou; Na Hou; Cheng He
Journal:  BMC Vet Res       Date:  2012-07-02       Impact factor: 2.741

7.  Human infection with influenza virus A(H10N8) from live poultry markets, China, 2014.

Authors:  Tao Zhang; Yuhai Bi; Huaiyu Tian; Xiaowen Li; Di Liu; Ying Wu; Tao Jin; Yong Wang; Quanjiao Chen; Ze Chen; Jianyu Chang; George F Gao; Bing Xu
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

Review 8.  Current situation of H9N2 subtype avian influenza in China.

Authors:  Min Gu; Lijun Xu; Xiaoquan Wang; Xiufan Liu
Journal:  Vet Res       Date:  2017-09-15       Impact factor: 3.683

9.  Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999.

Authors:  Timothy M Uyeki; Yu-Hoi Chong; Jacqueline M Katz; Wilina Lim; Yuk-Yin Ho; Sophia S Wang; Thomas H F Tsang; Winnie Wan-Yee Au; Shuk-Chi Chan; Thomas Rowe; Jean Hu-Primmer; Jensa C Bell; William W Thompson; Carolyn Buxton Bridges; Nancy J Cox; Kwok-Hang Mak; Keiji Fukuda
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

10.  A Single Mutation N166D in Hemagglutinin Affects Antigenicity and Pathogenesis of H9N2 Avian Influenza Virus.

Authors:  Fang Jin; Xiaomei Dong; Zhimin Wan; Dan Ren; Min Liu; Tuoyu Geng; Jianjun Zhang; Wei Gao; Hongxia Shao; Aijian Qin; Jianqiang Ye
Journal:  Viruses       Date:  2019-08-02       Impact factor: 5.048

View more
  2 in total

1.  Identification of a Novel Insertion Site HVT-005/006 for the Generation of Recombinant Turkey Herpesvirus Vector.

Authors:  Xusheng Zai; Bin Shi; Hongxia Shao; Kun Qian; Jianqiang Ye; Yongxiu Yao; Venugopal Nair; Aijian Qin
Journal:  Front Microbiol       Date:  2022-05-25       Impact factor: 6.064

2.  Identification of Hemagglutinin Mutations Caused by Neuraminidase Antibody Pressure.

Authors:  Fei Wang; Zhimin Wan; Yajuan Wang; Jinsen Wu; Hui Fu; Wei Gao; Hongxia Shao; Kun Qian; Jianqiang Ye; Aijian Qin
Journal:  Microbiol Spectr       Date:  2021-12-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.